Anixa receives Canadian patent allowance for ovarian cancer vaccine
Go back to Anixa receives Canadian patent allowance for ovarian cancer vaccine| (NASDAQ: ANIX) | Delayed: 2.77 -0.14 (4.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.91 | 52 Week High | $ | |||
| Open | $2.97 | 52 Week Low | $ | |||
| Day High | $2.97 | P/E | N/A | |||
| Day Low | $2.75 | EPS | $ | |||
| Volume | 285,078 | |||||

